Karin Wehlin
Chief Executive Officer presso DIAGONAL BIO AB
Profilo
Karin Wehlin is the founder of EQL Pharma AB, which was founded in 2006.
She is currently the Chief Executive Officer at Diagonal Bio AB since 2024.
Previously, she held the position of Chief Executive Officer at LU Food Science AB, BoMill AB, and Respiratorius AB.
Ms. Wehlin obtained an MBA from the University of Lund.
Posizioni attive di Karin Wehlin
| Società | Posizione | Inizio |
|---|---|---|
| DIAGONAL BIO AB | Chief Executive Officer | 28/02/2024 |
Precedenti posizioni note di Karin Wehlin
| Società | Posizione | Fine |
|---|---|---|
| BOMILL AB | Chief Executive Officer | - |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Chief Executive Officer | - |
| LU Food Science AB | Chief Executive Officer | - |
| EQL PHARMA AB | Founder | - |
Formazione di Karin Wehlin
| University of Lund | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| EQL PHARMA AB | Health Technology |
 | Health Technology |
| BOMILL AB | Technology Services |
| DIAGONAL BIO AB | Health Technology |
| Aziende private | 1 |
|---|---|
| LU Food Science AB |
- Borsa valori
- Insiders
- Karin Wehlin
